A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma
Year: 2000
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Bone Marrow Transplantation
Authors: P Stiff, R Gingrich, S Luger, MR Wyres, RA Brown, CF LeMaistre, J Perry, DP Schenkein, A List, JR Mason, W Bensinger, C Wheeler, C Freter, WRL Parker, C Emmanouilides
Institutions: University of Iowa, University of Pennsylvania, Amgen (United States), Washington University in St. Louis, Wake Forest University Health Sciences, Wake Forest University, Tufts Medical Center, University of Arizona, Scripps Clinic, Fred Hutch Cancer Center, Beth Israel Deaconess Medical Center, Georgetown University, University of California, Los Angeles
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Amgen
OpenAlex ID: W2335097692